Figure 3.
GnRH agonists are associated with significant excess risk of diabetes, coronary heart disease, myocardial infarction and sudden death. Largest excess risk is for diabetes (44%).32
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.